TSTara C. Serio

Tara C. Serio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tara C. Serio has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Angela Ragin-Wilson

    Office of the Associate Director, ATSDR, Atlanta, USA

    1 shared publication
  • Antonia M. Calafat

    Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, USA

    1 shared publication
  • Carol Cusack

    Office of Community Health Hazard Assessment , Agency for Toxic Substances and Disease Registry (ATSDR) , Atlanta , GA , USA

    1 shared publication
  • Carrie Tomasallo

    Wisconsin Department of Health Services, Division of Public Health, Bureau of Environmental and Occupational Health, Madison, USA

    1 shared publication
  • Elizabeth Irvin

    Office of Community Health Hazard Assessment, Agency for Toxic Substances and Disease Registry (ATSDR), Atlanta, USA

    1 shared publication
  • Julianne Cook Botelho

    Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, USA

    1 shared publication

Latest Publications

  • Open Access

    Biomonitoring of per- and polyfluoroalkyl substances (PFAS) in sportfish consumers in the Great Lakes – Milwaukee, Wisconsin

    by Tara C. Serio, Carrie Tomasallo, Xiaofei He, Elizabeth Irvin, Angela Ragin-Wilson, Teresa Wang, Julianne Cook Botelho, Antonia M. Calafat, Zheng Li

    Background: The Milwaukee Angler Study was initiated in 2017 as part of the Biomonitoring of Great Lakes Populations Program (BGLP-III) to examine two adult populations at high risk of per- and polyfluoroalkyl substances (PFAS) exposure from consumption of PFAS-contaminated sportfish: licensed anglers near the Milwaukee Estuary Area of Concern (AOC) and Burmese refugees for whom fish is a dietary staple. Objective: This study seeks to provide a comprehensive examination of serum PFAS concentrations in these groups and investigate associations with locally caught fish consumption. Methods: Licensed urban anglers and Burmese refugees were independently recruited using population-specific sampling strategies. Participants completed questionnaires on demographics and fish consumption and provided biological specimens. Median and 95th percentile concentrations of seven PFAS were compared to 2017–2018 National Health and Nutrition Examination Survey (NHANES) data. Multivariable regression assessed associations between serum PFAS concentrations and self-reported local fish consumption from the Milwaukee AOC. Results: Among the 396 licensed angler participants, serum concentrations of three of the seven PFAS (PFOS, PFHxS, PFNA) were elevated compared to the U.S. population; PFOS, PFDA, PFHxS, PFNA, and total PFAS were significantly associated with increased local fish consumption when controlling for other demographic factors. Among the 103 Burmese refugee participants, four of the seven measured PFAS (PFOS, PFDA, PFUnDA, PFNA) were elevated compared to the U.S. population; PFOA, PFOS, PFDA, and total PFAS were associated with increased local fish consumption when controlling for other demographic factors. Significance: The results from this study support an association of local fish consumption with PFAS exposure among high-risk populations with varied demographic and local fish consumption practices in the Milwaukee Estuary AOC. Given that adherence to and awareness of state fish advisories can vary widely, our biomonitoring results underscore the importance of ongoing, tailored efforts to deliver culturally relevant public health interventions to the diverse populations surrounding the Great Lakes basin. Impact statement: Building on the Biomonitoring of Great Lakes Populations program, this study adds PFAS-focused data from Milwaukee’s urban anglers and Burmese refugees, two understudied, high-exposure groups in the Milwaukee Estuary Area of Concern. By integrating detailed fish-consumption histories with serum PFAS and NHANES comparisons, the work directly informs Great Lakes Restoration Initiative goals and targeted fish-advisory interventions. These findings offer actionable evidence for exposure scientists, environmental epidemiologists, and public health practitioners.

  • Lead and cancer: a narrative review and risk of bias assessment (2003–2020)

    by Carol Cusack, Tara C. Serio, Noelle B. Henderson, Kathryn B. Egan, Zheng Li, Teresa W. Wang

    Lead exposure may contribute to harmful human health effects, but evidence of its carcinogenicity is limited. The International Agency for Research on Cancer (IARC) in 2006 classified lead as “probably carcinogenic” (Group 2A), based on limited evidence in humans and sufficient evidence in animals. To further synthesize evidence on lead’s carcinogenicity, this review included a literature search and risk of bias assessment of 43 peer-reviewed epidemiological studies on lead exposure and cancer outcomes published between 2003 and 2020. Using the National Toxicology Program’s Office of Health Assessment and Translation Risk of Bias approach, 13 Tier One studies (primarily low risk) and 30 Tier Two studies (low and high risk) were identified. These studies characterized lead exposure through biologic media (i.e., blood, urine, tissues, hair, nails), and/or work histories, and evaluated cancers of the biliary tract, brain and central nervous system, breast, digestive tract, head and neck, blood, mesothelium, reproductive organs, respiratory tract, skin, thyroid, and urinary tract. Notably, breast, thyroid, and head and neck cancers were not previously included in the IARC 2006 monograph. Across all site-specific cancers examined, at least one study reported an association with lead exposure except for skin cancer. Respiratory tract cancers had the most epidemiologic studies showing positive associations with lead exposure. Study limitations were commonly tied to risk of bias for confounding, exposure characterization, and outcome assessments. Taken together, future studies would benefit from robust experimental designs with thorough adjustments for confounders, large diverse populations, and standardized exposure assessments particularly for cancers with limited data.